Ontak



Indications and Reactions:

Role Indications Reactions
Primary
Peripheral T-cell Lymphoma Unspecified 14.3%
Premedication 14.1%
Hypertension 12.2%
T-cell Lymphoma 10.5%
Mycosis Fungoides 8.6%
Nausea 5.1%
Pain 4.3%
Constipation 3.5%
Lymphoma 3.5%
Peripheral T-cell Lymphoma Unspecified Recurrent 3.0%
Vomiting 3.0%
Gastrointestinal Pain 2.4%
Mycosis Fungoides Stage Iii 2.2%
Anticoagulant Therapy 1.9%
Eczema 1.9%
Fatigue 1.9%
Hypokalaemia 1.9%
Infection 1.9%
Osteoarthritis 1.9%
Vitamin Supplementation 1.9%
Vomiting 11.2%
Lymphopenia 8.2%
Unresponsive To Stimuli 8.2%
Pyrexia 7.1%
Febrile Neutropenia 6.1%
Pain 6.1%
Mental Status Changes 5.1%
Sepsis 5.1%
Thrombocytopenia 5.1%
Weight Increased 5.1%
Capillary Leak Syndrome 4.1%
Infection 4.1%
Neoplasm Malignant 4.1%
Rhabdomyolysis 4.1%
Atrial Tachycardia 3.1%
Syncope 3.1%
Thrombosis 3.1%
Tumour Lysis Syndrome 3.1%
Acute Graft Versus Host Disease In Intestine 2.0%
Blindness 2.0%
Secondary
Peripheral T-cell Lymphoma Unspecified 33.3%
Premedication 20.7%
Mycosis Fungoides 6.0%
Prophylaxis 6.0%
Infection 4.0%
Pain 4.0%
T-cell Lymphoma 3.3%
B-cell Lymphoma 2.7%
Depression 2.7%
Hypercholesterolaemia 2.7%
Hypertension 2.7%
Hypothyroidism 2.7%
Anaplastic Large-cell Lymphoma 1.3%
Mycosis Fungoides Stage I 1.3%
Mycosis Fungoides Stage Iii 1.3%
Ovarian Cancer Metastatic 1.3%
Pemphigoid 1.3%
Renal Tubular Disorder 1.3%
Adult T-cell Lymphoma/leukaemia 0.7%
Oedema Peripheral 0.7%
Thrombocytopenia 14.3%
Pruritus 11.4%
Pyrexia 8.6%
Gastrointestinal Disorder 5.7%
Generalised Oedema 5.7%
Pain 5.7%
Skin Lesion 5.7%
Skin Necrosis 5.7%
Tumour Lysis Syndrome 5.7%
Bone Pain 2.9%
Capillary Leak Syndrome 2.9%
Death 2.9%
Enterocolitis Haemorrhagic 2.9%
Lymphopenia 2.9%
Oedema Peripheral 2.9%
Pain In Extremity 2.9%
Pancytopenia 2.9%
Peripheral Sensory Neuropathy 2.9%
Pneumonitis 2.9%
Pulmonary Fibrosis 2.9%
Concomitant
Eczema 77.8%
Product Used For Unknown Indication 22.2%
White Blood Cell Count Increased 57.1%
Sunburn 28.6%
Asthenia 14.3%